[an error occurred while processing this directive] | [an error occurred while processing this directive]
Controversies and progresses in prophylactic cranial irradiation for small cell lung cancer
Sun Han, Zhao Lujun
Department of Radiation Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin’s Clinical Research Center for Cancer,Tianjin 300060,China
Abstract Small cell lung cancer (SCLC) is a kind of highly invasive malignant neoplasm, which is characterized by short survival and high-risk cranial metastasis. Therefore, application of prophylactic cranial irradiation (PCI) is of clinical significance to reduce the incidence of brain metastasis and prolong the patients’ survival on the basis of radio-and chemo-therapy. Nevertheless, the indications and clinical value of PCI have been controversial in recent years. These controversies mainly include the significance of PCI for extensive-stage SCLC, the indications of PCI for limited-stage SCLC and the alternative approaches for PCI. In this paper, the controversies and progresses of PCI applied in clinical practice are investigated and reviewed.
Sun Han,Zhao Lujun. Controversies and progresses in prophylactic cranial irradiation for small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(1): 112-115.
Sun Han,Zhao Lujun. Controversies and progresses in prophylactic cranial irradiation for small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(1): 112-115.
[1] Arriagada R,Le Chevalier T,Borie F,et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission[J].J Natl Cancer Inst,1995,87(3):183-190.DOI:10.1093/jnci/87.3.183 [2] Postmus PE,Haaxma-Reiche H,Gregor A,et al. Brain-only metastases of small cell lung cancer;efficacy of whole brain radiotherapy. An EORTC phase Ⅱ study[J].Radiother Oncol,1998,46(1):29-32.DOI:10.1016/S0167-8140(97)00149-7 [3] Hansen HH.Should initial treatment of small cell carcinoma include systemic chemotherapy and brain irradiation?[J].Cancer Chemother Rep 3,1973,4(2):239-241 [4] Aupérin A,Arriagada R,Pignon JP,et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission[J].N Engl J Med,1999,341(7):476-484.DOI:10.1056/NEJM199908123410703 [5] Slotman B,Faivre-Finn C,Kramer G,et al. Prophylactic cranial irradiation in extensive small-cell lung cancer[J].N Engl J Med,2007,357(7):664-672.DOI:10.1056/NEJMoa071780 [6] Seto T,Takahashi T,Yamanaka T,et al. Prophylactic cranial irradiation (PCI) has a detrimental effect on the overall survival (OS) of patients (pts) with extensive disease small cell lung cancer (ED-SCLC):results of a Japanese randomized phase Ⅲ trial[J].J Clin Oncol 2014,32(15S):7503.DOI:10.1200/jco.2014.32.15_suppl.7503 [7] Nosaki K,Seto T.The role of radiotherapy in the treatment of small-cell lung cancer[J].Curr Treat Options Oncol,2015,16(12):56.DOI:10.1007/s11864-015-0372-2 [8] Cross NE,Glantz MJ.Neurologic complications of radiation therapy[J].Neurol Clin,2003,21(1):249-277.DOI:10.1016/S0733-8619(02)00031-2 [9] Seute T,Leffers P,ten Velde GPM,et al. Detection of brain metastases from small cell lung cancer:consequences of changing imaging techniques (CT versus MRI)[J].Cancer,2008,112(8):1827-1834.DOI:10.1002/cncr.23361 [10] Manapov F,Klautke G,Fietkau R.Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy:a single institution experience[J].J Thorac Oncol,2008,3(6):652-655.DOI:10.1097/JTO.0b013e3181757a76 [11] Laukkanen E,Klonoff H,Allan B,et al. The role of prophylactic brain irradiation in limited stage small cell lung cancer:clinical,neuropsychologic,and CT sequelae[J].Int J Radiat Oncol Biol Phys,1988,14(6):1109-1117.DOI:10.1016/0360-3016(88)90386-0 [12] Ohonoshi T,Ueoka H,Kawahara S,et al. Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response:a long-term follow-up result[J].Lung Cancer,1993,10(1-2):47-54.DOI:10.1016/0169-5002(93)90308-K [13] Bernhardt D,Adeberg S,Bozorgmehr F,et al. Nine-year experience:Prophylactic cranial irradiation in extensive disease small-cell lung cancer[J].Clin Lung Cancer,2017,18(4):e267-e271.DOI:10.1016/j.cllc.2016.11.012 [14] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines®):small cell lung cancer[M].Fort Washington:NCCN,2016 [15] Yamamoto M,Serizawa T,Shuto T,et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901):a multi-institutional prospective observational study[J].Lancet Oncol,2014,15(4):387-395.DOI:10.1016/S1470-2045(14)70061-0 [16] Jo KW,Kong DS,Lim DH,et al. The role of radiosurgery in patients with brain metastasis from small cell lung carcinoma[J].J Korean Neurosurg Soc,2011,50(2):99-102.DOI:10.3340/jkns.2011.50.2.99 [17] Harris S,Chan MD,Lovato JF,et al. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2012,83(1):e53-e59.DOI:10.1016/j.ijrobp.2011.11.059 [18] Wegner RE,Olson AC,Kondziolka D,et al. Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2011,81(3):e21-e27.DOI:10.1016/j.ijrobp.2011.01.001 [19] Ozawa Y,Omae M,Fujii M,et al. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer[J].BMC Cancer,2015,15:589.DOI:10.1186/s12885-015-1593-2 [20] Arriagada R,Le Chevalier T,Rivière A,et al. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer:analysis of 505 randomized patients[J].Ann Oncol,2002,13(5):748-754.DOI:10.1093/annonc/mdf123 [21] Meert AP,Paesmans M,Berghmans T,et al. Prophylactic cranial irradiation in small cell lung cancer:a systematic review of the literature with meta-analysis[J].BMC Cancer,2001,1:5.DOI:10.1186/1471-2407-1-5 [22] Nakamura H,Kato Y,Kato H.Outcome of surgery for small cell lung cancer-response to induction chemotherapy predicts survival[J].Thorac Cardiovasc Surg,2004,52(4):206-210.DOI:10.1055/s-2004-821075 [23] Tsuchiya R,Suzuki K,Ichinose Y,et al. Phase Ⅱ trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage Ⅰ—Ⅲ a small cell lung cancer:the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)[J].J Thorac Cardiovasc Surg,2005,129(5):977-983.DOI:10.1016/j.jtcvs.2004.05.030 [24] Gong LL,Wang QI,Zhao LJ,et al. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery:is prophylactic cranial irradiation necessary for stage Ⅰ—Ⅲ disease?[J].Int J Radiat Oncol Biol Phys,2013,85(1):196-200.DOI:10.1016/j.ijrobp.2012.03.038 [25] Zhu H,Guo HB,Shi F,et al. Prophylactic cranial irradiation improved the overall survival of patients with surgically resected small cell lung cancer,but not for stage Ⅰ disease[J].Lung Cancer,2014,86(3):334-338.DOI:10.1016/j.lungcan.2014.09.019 [26] Wu AJ,Gillis A,Foster A.Should all limited-stage small cell lung cancer be treated alike? Impact of AJCC stage on brain metastasis,survival,and patterns of failure[J].Int J Radiat Oncol Bio Phys,2014,90(Suppl 1):S61.DOI:10.1016/j.ijrobp.2014.05.210 [27] Yang CFJ,Chan DY,Speicher PJ,et al. Role of adjuvant therapy in a population-based cohort of patients with early-stage small-cell lung cancer[J].J Clin Oncol,2016,34(10):1057-1064.DOI:10.1200/JCO.2015.63.8171 [28] Sun A,Bae K,Gore EM,et al. Phase Ⅲ trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer:neurocognitive and quality-of-life analysis[J].J Clin Oncol,2011,29(3):279-286.DOI:10.1200/JCO.2010.29.6053 [29] Le Péchoux C,Laplanche A,Faivre-Finn C,et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase Ⅲ trial (PCI99-01,EORTC 22003-08004,RTOG 0212 and IFCT 99-01)[J].Ann Oncol,2011,22(5):1154-1163.DOI:10.1093/annonc/mdq576 [30] Wolfson AH,Bae K,Komaki R,et al. Primary analysis of a phase Ⅱ randomized trial Radiation Therapy Oncology Group (RTOG) 0212:impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2011,81(1):77-84.DOI:10.1016/j.ijrobp.2010.05.013 [31] Talarico L,Chen G,Pazdur R.Enrollment of elderly patients in clinical trials for cancer drug registration:a 7-year experience by the US Food and Drug Administration[J].J Clin Oncol,2004,22(22):4626-4631.DOI:10.1200/JCO.2004.02.175 [32] Eaton BR,Kim S,Marcus DM,et al. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer[J].Cancer,2013,119(21):3753-3760.DOI:10.1002/cncr.28267 [33] Rule WG,Foster NR,Meyers JP,et al. Prophylactic cranial irradiation in elderly patients with small cell lung cancer:findings from a North Central Cancer Treatment Group pooled analysis[J].J Geriatr Oncol,2015,6(2):119-126.DOI:10.1016/j.jgo.2014.11.002 [34] Farooqi AS,Holliday EB,Allen PK,et al. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer:Do all patients benefit?[J].Radiother Oncol,2017,122(2):307-312.DOI:10.1016/j.radonc.2016.11.012 [35] Brown PD,Pugh S,Laack NN,et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy:a randomized,double-blind,placebo-controlled trial[J].Neuro Oncol,2013,15(10):1429-1437.DOI:10.1093/neuonc/not114 [36] Gondi V,Pugh SL,Tome WA,et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933):a phase Ⅱ multi-institutional trial[J].J Clin Oncol,2014,32(34):3810-3816.DOI:10.1200/JCO.2014.57.2909
2018, Vol. 27 
